KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Exchange Rate Effect (2021 - 2025)

Historic Exchange Rate Effect for AbCellera Biologics (ABCL) over the last 5 years, with Q3 2025 value amounting to -$544000.0.

  • AbCellera Biologics' Exchange Rate Effect fell 24822.89% to -$544000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.4 million, marking a year-over-year decrease of 32144.03%. This contributed to the annual value of -$2.6 million for FY2024, which is 54431.24% down from last year.
  • According to the latest figures from Q3 2025, AbCellera Biologics' Exchange Rate Effect is -$544000.0, which was down 24822.89% from $761000.0 recorded in Q2 2025.
  • Over the past 5 years, AbCellera Biologics' Exchange Rate Effect peaked at $1.1 million during Q4 2023, and registered a low of -$8.6 million during Q3 2022.
  • Its 5-year average for Exchange Rate Effect is -$644473.7, with a median of -$213000.0 in 2023.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first plummeted by 384101.38% in 2022, then soared by 186976.74% in 2025.
  • AbCellera Biologics' Exchange Rate Effect (Quarter) stood at -$525000.0 in 2021, then skyrocketed by 169.33% to $364000.0 in 2022, then skyrocketed by 193.41% to $1.1 million in 2023, then plummeted by 302.25% to -$2.2 million in 2024, then soared by 74.81% to -$544000.0 in 2025.
  • Its Exchange Rate Effect was -$544000.0 in Q3 2025, compared to $761000.0 in Q2 2025 and $590000.0 in Q1 2025.